Roberton James Stevenson Sells 284 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Roberton James Stevenson sold 284 shares of Addus HomeCare stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $29,922.24. Following the sale, the executive vice president directly owned 14,030 shares in the company, valued at $1,478,200.80. The trade was a 1.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Roberton James Stevenson also recently made the following trade(s):

• On Tuesday, February 24th, Roberton James Stevenson sold 567 shares of Addus HomeCare stock. The stock was sold at an average price of $107.35, for a total value of $60,867.45.

Addus HomeCare Price Performance

Shares of ADUS opened at $103.53 on Friday. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $124.43. The stock’s fifty day moving average is $109.22 and its 200-day moving average is $112.95. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91.

Wall Street Analyst Weigh In

ADUS has been the topic of several recent analyst reports. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday, February 23rd. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $134.33.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently made changes to their positions in the company. Capital Research Global Investors boosted its stake in Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares during the period. Tributary Capital Management LLC lifted its holdings in shares of Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares in the last quarter. Freestone Grove Partners LP boosted its position in shares of Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after buying an additional 135,246 shares during the period. 8 Knots Management LLC acquired a new stake in shares of Addus HomeCare in the third quarter worth $6,075,000. Finally, TimesSquare Capital Management LLC grew its holdings in shares of Addus HomeCare by 13.9% during the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock valued at $45,390,000 after buying an additional 48,207 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.